This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Recent Trends

Ronald H. Spiro, MD; John Armstrong, MB, BCh; Louis Harrison, MD; Nancy L. Geller, PhD; Shiow-Yun Lin, MS; Elliot W. Strong, MD

Arch Otolaryngol Head Neck Surg. 1989;115(3):316-321.

Abstract
• We have reviewed a 44-year experience with previously untreated carcinomas arising in major salivary glands to compare 319 patients treated before 1966 with 155 who received therapy between 1966 and 1982. Actuarial analysis indicates that five- and ten-year survival of our more recently treated patients was 80% and 65%, compared with 60% and 50% in patients treated before 1966. Explanation for this includes the higher proportion of patients with less aggressive histologic subtypes seen in recent years, as well as the fact that many of our patients treated before 1966 had surgical procedures considered inadequate by current standards. We also believe that adjunctive radiation oncology enhanced survival, but it could not be proved in this retrospective study. Multivariate analysis confirms that the clinical stage was the most important prognostic variable.

(Arch Otolaryngol Head Neck Surg 1989;115:316-321)

Author Affiliations
From the Head and Neck Service, Departments of Surgery (Drs Spiro and Strong), Radiation Oncology (Drs Armstrong and Harrison), and Biostatistics (Dr Geller and Ms Lin), Memorial Sloan-Kettering Cancer Center, New York.

Footnotes
Accepted for publication Sept 21, 1988.

Read before the Second International Conference on Head and Neck Cancer, Boston, Aug 1, 1988.

Reprint requests to 425 E 67th St, New York, NY 10021 (Dr Spiro).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of Initial Treatment on Disease Outcome for Patients With Submandibular Gland Carcinoma
Kaszuba et al.
Arch Otolaryngol Head Neck Surg 2007;133:546-550.
ABSTRACT | FULL TEXT  

Mucoepidermoid carcinoma of the parotid gland in children: A 10-year experience.
Rahbar et al.
Arch Otolaryngol Head Neck Surg 2006;132:375-380.
ABSTRACT | FULL TEXT  

Gene Expression Screening of Salivary Gland Neoplasms: Molecular Markers of Potential Histogenetic and Clinical Significance
Maruya et al.
J. Mol. Diagn. 2004;6:180-190.
ABSTRACT | FULL TEXT  

Treatment of Salivary Gland Neoplasms With Fast Neutron Radiotherapy
Douglas et al.
Arch Otolaryngol Head Neck Surg 2003;129:944-948.
ABSTRACT | FULL TEXT  

High Incidence of Lymph Node Metastasis in Major Salivary Gland Cancer
Stennert et al.
Arch Otolaryngol Head Neck Surg 2003;129:720-723.
ABSTRACT | FULL TEXT  

Multivariate Analysis of Risk Factors for Neck Metastases in Surgically Treated Parotid Carcinomas
Regis de Brito Santos et al.
Arch Otolaryngol Head Neck Surg 2001;127:56-60.
ABSTRACT | FULL TEXT  

Primary Parotid Malignancies: A Clinical and Pathologic Review
Kane et al.
Arch Otolaryngol Head Neck Surg 1991;117:307-315.
ABSTRACT  

Submandibular Gland Tumors: Adverse Histologic Factors and Therapeutic Implications
Weber et al.
Arch Otolaryngol Head Neck Surg 1990;116:1055-1060.
ABSTRACT  

Malignant Tumors of Major Salivary Gland Origin: A Matched-Pair Analysis of the Role of Combined Surgery and Postoperative Radiotherapy
Armstrong et al.
Arch Otolaryngol Head Neck Surg 1990;116:290-293.
ABSTRACT